Funds holding ARS Pharmaceuticals Inc
ISIN US82835W1080 · United States
- Fund holders
- 138
- Of which ETFs
- 29 109 other funds
- Value held
- ≈ 110.5M $ 109.4M $ · 1M €
- Share of capital
- 13.3 % of 99.4M shares on Aug 11, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 2,669 | 21.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 2,556 | 23.7K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| FlexShares Morningstar US Market Factor Tilt Index Fund FlexShares Trust | 2,544 | 21K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,059 | 16.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 2,051 | 16.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 1,925 | 15.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,593 | 12.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,557 | 14.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 1,513 | 12.5K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,502 | 12.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,401 | 11.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,400 | 11.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 1,371 | 11.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 1,125 | 9.3K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 1,100 | 8.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 998 | 8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 928 | 7.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 692 | 5.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 666 | 5.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 552 | 4.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 407 | 3.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 298 | 2.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 286 | 2.3K $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 280 | 2.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 197 | 1.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 149 | 1.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 147 | 1.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 129 | 1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 108 | 892.1 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 77 | 618.3 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 65 | 603.2 $ | 0.00 % | as of Feb 27, 2026 ↗ | |
| ProShares Hedge Replication ETF ProShares Trust | 61 | 566.1 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 58 | 465.7 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 26 | 214.8 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 17 | 157.8 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 15 | 120.5 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 644.4K € | 0.78 % | as of Dec 31, 2025 ↗ | ||
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 370.1K € | 0.99 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 0.99 % | as of Dec 31, 2025 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.78 % | as of Dec 31, 2025 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.59 % | as of Feb 28, 2026 ↗ |
| BARON DISCOVERY FUND BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.53 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus Small Cap Equity Fund ADVISORS' INNER CIRCLE III | 0.50 % | as of Apr 30, 2026 ↗ |
| Allspring Small Company Growth Fund ALLSPRING FUNDS TRUST | 0.47 % | as of Apr 30, 2026 ↗ |
| Sit Small Cap Growth Fund SIT MUTUAL FUNDS INC | 0.47 % | as of Mar 31, 2026 ↗ |
| Royce Smaller-Companies Growth Fund ROYCE FUND | 0.24 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.24 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.23 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 136 | -6 | 13,239,940 | -10.1 % |
| 2026Q1 | 142 | -13 | 14,727,175 | +1.1 % |
| 2025Q4 | 155 | -3 | 14,570,388 | -8.0 % |
| 2025Q3 | 158 | +8 | 15,837,621 | +0.9 % |
| 2025Q2 | 150 | +4 | 15,697,185 | -3.2 % |
| 2025Q1 | 146 | +7 | 16,212,800 | +24.4 % |
| 2024Q4 | 139 | +13 | 13,033,296 | +21.9 % |
| 2024Q3 | 126 | +2 | 10,694,967 | +9.0 % |
| 2024Q2 | 124 | +18 | 9,807,884 | +19.5 % |
| 2024Q1 | 106 | -7 | 8,206,609 | -14.3 % |
| 2023Q4 | 113 | 9,571,133 |
Institutional managers
193 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10,860,977 | 87.2M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 8,288,510 | 66.6M $ | as of Mar 31, 2026 |
| Rubric Capital Management LP | 8,000,000 | 64.2M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 7,503,812 | 60.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 5,982,919 | 48M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,012,254 | 40.2M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 4,113,617 | 33M $ | as of Mar 31, 2026 |
| SR One Capital Management, LP | 4,012,903 | 32.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,644,966 | 29.3M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 3,278,549 | 26.3M $ | as of Mar 31, 2026 |
| Tyro Capital Management LLC | 2,968,599 | 23.8M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,260,325 | 18.2M $ | as of Mar 31, 2026 |
| Janney Montgomery Scott LLC | 2,016,464 | 16.2K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,773,188 | 14.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,526,824 | 12.3M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,361,536 | 10.9M $ | as of Mar 31, 2026 |
| BAMCO INC /NY/ | 1,273,341 | 10.2M $ | as of Mar 31, 2026 |
| Third Point LLC | 1,000,000 | 8M $ | as of Mar 31, 2026 |
| GENERAL AMERICAN INVESTORS CO INC | 727,154 | 5.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 724,219 | 5.8M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 610,703 | 4.9M $ | as of Mar 31, 2026 |
| K2 PRINCIPAL FUND, L.P. | 559,697 | 4.5M $ | as of Mar 31, 2026 |
| LEVIN CAPITAL STRATEGIES, L.P. | 552,561 | 4.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 533,394 | 4.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 529,284 | 4.3M $ | as of Mar 31, 2026 |
Declared shareholders of ARS Pharmaceuticals Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Rubric Capital Management LP and 1 other | 8.06 % | 8,000,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 4.98 % | 4,946,412 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ARS Pharmaceuticals Inc". https://titelia.com/en/stocks/ars-pharmaceuticals-inc-US82835W1080